Navigation Links
Amylin Pharmaceuticals Reports 2008 Financial Results
Date:1/27/2009

nts and our shareholders by capitalizing on key market drivers, such as the American Diabetes Association's inclusion of BYETTA as the only new addition to their treatment guidelines. Our focus remains on increasing BYETTA revenue, submitting the New Drug Application (NDA) for exenatide once weekly, significantly improving operating results and progressing toward positive operating cash flow by the end of 2010."

Quarter ended December 31, 2008

Net product sales of $184.9 million for the quarter include sales of $162.7 million for BYETTA(R) (exenatide) injection and $22.2 million for SYMLIN(R) (pramlintide acetate) injection. This compares to net product sales of $194.7 million, consisting of $176.3 million for BYETTA and $18.4 million for SYMLIN for the same period in 2007.

Revenue under collaborative agreements was $17.6 million for the quarter ended December 31, 2008, compared to $27.3 million for the same period in 2007. The decrease reflects lower cost-sharing payments from Eli Lilly and Company for BYETTA and exenatide once weekly development expenses.

Selling, general and administrative expenses decreased to $86.1 million for the quarter ended December 31, 2008 from $122.4 million for the same period in 2007. The decrease primarily reflects lower promotional spending for BYETTA and the Company's reduced cost structure following its restructuring.

Research and development expenses decreased to $67.0 million for the quarter ended December 31, 2008 from $83.9 million for the same period in 2007. The decrease primarily reflects lower development expenses for exenatide once weekly and the Company's reduced cost structure following its restructuring.

Collaborative profit sharing, which represents Lilly's share of the gross margin for BYETTA, was $73.2 million for the quarter ended December 31, 2008, compared to $78.6 million for the same period in 2007.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Amylin Pharmaceuticals to Webcast Year-End Results
2. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
3. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
4. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
5. Lilly and Amylin Set Date and Time for Conference Call
6. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
7. Amylin Pharmaceuticals Reports First Quarter Financial Results
8. Amylin Pharmaceuticals Reports 2007 Financial Results
9. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
10. Amylin Pharmaceuticals to Present at Research & Development Day
11. Amylin Pharmaceuticals to Webcast Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Hills, California (PRWEB) December 25, 2014 ... her home in Woodland Hills, California after an 8 ... passed away on Christmas Eve evening in her home ... with aggressive metastatic breast cancer. , ... for over forty years, she pioneered and championed many ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... receive effective, less expensive care from a clinic that functions ... of dedicated health care professionals, a new study shows. ... either hospitalization or a trip to the emergency room when ... the University of Texas in Houston versus usual care, according ...
(Date:12/25/2014)... Among early stage breast cancer patients who undergo chemotherapy ... will eventually develop leukemia as a result of their ... from a review of more than 20,000 breast cancer ... that the risk for developing treatment-related leukemia, though low, ... "The frequency of bone marrow cancers such as leukemia ...
(Date:12/25/2014)... December 25, 2014 Thousands of transvaginal ... forward in a number of multidistrict litigations currently underway ... Bernstein Liebhard LLP reports. According to an Order issued ... convene a Joint Status Conference in all of the ... have been directed to submit a proposed agenda to ...
(Date:12/25/2014)... Carolina (PRWEB) December 25, 2014 ... Carolina Retirement Community, recently showed their generous spirit ... of the Catawba County Parenting Network- Grandparents Raising ... 10 children gathered around the largest Christmas tree ... open presents purchased by residents of the Abernethy ...
Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Cardium Therapeutics,(Amex: CXM ) today announced the completion ... debt with accompanying warrants to purchase shares of,common stock, ... paid,off last quarter. Empire Asset Management Company acted as ... and the Barone,Group acted as lead investor. The material ...
... cause short-term neurological problems in children and teenagers ... to pediatric researchers. The new finding contrasts favorably ... after newborn surgery for more complex heart conditions. ... who receive surgery for these less complex heart ...
... a Tucson based,drug delivery device company, announced the ... to the company,s medical Advisory Board. Both,Swenson and ... Hospital, Hospice and Home care settings., David ... Medical,Center and the Fred Hutchinson Cancer Research Center ...
... 10 Text messaging has,rapidly become a favorite form ... is a public health risk, says the American,Medical Association ... meeting. The AMA voted today to advocate for state,legislation ... while,driving., "Texting while driving takes the driver,s attention ...
... was tied to eye infection outbreak in U.S. , , ... high temperatures degrades the antifungal properties of the ReNu ... a U.S. eye infection outbreak between 2004 and 2006, ... a microbial agent not found in other contact lens ...
... On November 3, 2008,The Centers for Medicare ... a new code E0770 with the descriptor (functional,electrical ... type, complete system, not otherwise specified) which will ... incomplete spinal cord,injuries effective January 1, 2009. This ...
Cached Medicine News:Health News:Cardium Completes $6.0 Million Financing 2Health News:Cardium Completes $6.0 Million Financing 3Health News:Cardium Completes $6.0 Million Financing 4Health News:No drop in IQ seen after bypass for child heart surgery 2Health News:Medipacs Appoints Advisory Board Members 2Health News:High Temps Degrade Contact Lens Solution: Study 2Health News:Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide 2Health News:Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide 3
(Date:12/24/2014)... 2014 Kinex Pharmaceuticals announced today that the ... Park Cancer Institute. KX2-361 (KX02), a dual ... shown potent inhibitory activity against a broad panel of ... to Temozolomide (T98G), the most widely used chemotherapy for ... tumor mouse model, KX2-361 consistently clears brain tumors after ...
(Date:12/24/2014)... CRANBURY, N.J. and FARMINGTON, ... Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical ... treatment of diseases with significant unmet medical need ... closed on a private placement of 2,050,000 shares ... to purchase 24,949,325 shares of its common stock.  ...
(Date:12/24/2014)... DIEGO , Dec. 23, 2014 ResMed (NYSE: ... significant patent infringement action against Chinese medical device manufacturer BMC ... (ITC) ruled today that BMC,s masks listed below infringe ResMed,s ... or selling these masks in the United States ... iVolve N2 nasal mask , Willow nasal pillows mask ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
... fast and effective resection of meniscal tears ... rim. The flat, crescent-shaped tip has an ... tightest joint spaces. Made in the U.S. ... engineering experience in arthroscopy hand instrument design ...
... The WideBiter Punch series facilitates fast and ... a smooth, anatomically shaped meniscal rim. The ... profile to access even the tightest joint ... California, Inc., 20 years of engineering experience ...
... fast and effective resection of meniscal tears ... rim. The flat, crescent-shaped tip has an ... tightest joint spaces. Made in the U.S. ... engineering experience in arthroscopy hand instrument design ...
Medicine Products: